Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

Ver fuente original → ← Volver a noticias